In this episode of OncoInfluencers, Dr. Gevorg Tamamyan speaks with Dr. Charles M. Balch, Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center.
Dr. Balch reflects on his career spanning surgical oncology, tumor immunology, and executive leadership across major institutions, including MD Anderson, ASCO, and City of Hope. The discussion focuses on the evolution of cancer care, from surgery-dominant approaches to precision medicine and immunotherapy and the growing importance of prevention, early detection, and genetic risk assessment.
Key topics include:
- The transition toward personalized oncology and population-based screening
- The role of germline genetics in future healthcare
- Organizational leadership and building high-performing teams
- Structural innovations in cancer care delivery
- Priorities for reducing global cancer burden
This conversation provides practical insights for clinicians, researchers, and healthcare leaders working to improve cancer outcomes worldwide.